Genetically engineered two-warhead evasins provide a method to achieve precision targeting of disease-relevant chemokine subsets

Alenazi Y., Singh K., Davies G., Eaton JRO., Elders P., Kawamura A., Bhattacharya S.

DOI

10.1038/s41598-018-24568-9

Type

Journal article

Journal

Scientific Reports

Publisher

Springer Science and Business Media LLC

Publication Date

12/2018

Volume

8

Permalink Original publication